Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Fertility Preservation in Female Patients with Breast Cancer - a Current Overview.

Guenther V, Alkatout I, Junkers W, Bauerschlag D, Maass N, von Otte S.

Geburtshilfe Frauenheilkd. 2017 Oct;77(10):1088-1094. doi: 10.1055/s-0043-119543. Epub 2017 Oct 26.

2.

Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.

Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, Ben-Haroush A, Freud E, Kravarusic D, Sapir O, Fisch B.

Hum Reprod. 2016 Apr;31(4):750-62. doi: 10.1093/humrep/dew007. Epub 2016 Feb 4.

PMID:
26848188
3.

Cryobiology in human assisted reproductive technology. Would Hippocrates approve?

Bredkjaer HE, Grudzinskas JG.

Early Pregnancy. 2001 Jul;5(3):211-3.

PMID:
11753534
4.

Fertility after breast cancer treatment.

Kasum M, Beketić-Orešković L, Peddi PF, Orešković S, Johnson RH.

Eur J Obstet Gynecol Reprod Biol. 2014 Feb;173:13-8. doi: 10.1016/j.ejogrb.2013.11.009. Epub 2013 Nov 17. Review.

PMID:
24315568
5.

Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.

Das M, Shehata F, Son WY, Tulandi T, Holzer H.

Hum Reprod. 2012 Aug;27(8):2509-14. doi: 10.1093/humrep/des143. Epub 2012 May 22.

PMID:
22617122
6.

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

Meirow D, Raanani H, Maman E, Paluch-Shimon S, Shapira M, Cohen Y, Kuchuk I, Hourvitz A, Levron J, Mozer-Mendel M, Brengauz M, Biderman H, Manela D, Catane R, Dor J, Orvieto R, Kaufman B.

Fertil Steril. 2014 Aug;102(2):488-495.e3. doi: 10.1016/j.fertnstert.2014.05.017. Epub 2014 Jun 14.

PMID:
24934489
7.

Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.

Suzuki N, Yoshioka N, Takae S, Sugishita Y, Tamura M, Hashimoto S, Morimoto Y, Kawamura K.

Hum Reprod. 2015 Mar;30(3):608-15. doi: 10.1093/humrep/deu353. Epub 2015 Jan 6.

PMID:
25567618
8.

Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.

Imbert R, Moffa F, Tsepelidis S, Simon P, Delbaere A, Devreker F, Dechene J, Ferster A, Veys I, Fastrez M, Englert Y, Demeestere I.

Hum Reprod. 2014 Sep;29(9):1931-40. doi: 10.1093/humrep/deu158. Epub 2014 Jun 22.

PMID:
24958067
9.

Present and future fertility preservation strategies for female cancer patients.

Georgescu ES, Goldberg JM, du Plessis SS, Agarwal A.

Obstet Gynecol Surv. 2008 Nov;63(11):725-32. doi: 10.1097/OGX.0b013e318186aaea. Review.

PMID:
18928577
10.

[Fertility preservation in prepubertal children].

Poirot C, Schubert B.

Bull Cancer. 2011 May;98(5):489-99. doi: 10.1684/bdc.2011.1362. Review. French.

11.

Fertility preservation using controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome.

Reichman DE, Davis OK, Zaninovic N, Rosenwaks Z, Goldschlag DE.

Fertil Steril. 2012 Nov;98(5):1225-8. doi: 10.1016/j.fertnstert.2012.07.1056. Epub 2012 Aug 9.

PMID:
22884018
12.

GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.

Bildik G, Akin N, Senbabaoglu F, Sahin GN, Karahuseyinoglu S, Ince U, Taskiran C, Selek U, Yakin K, Guzel Y, Ayhan C, Alper E, Cetiner M, Balaban B, Mandel NM, Esen T, Iwase A, Urman B, Oktem O.

Hum Reprod. 2015 Dec;30(12):2912-25. doi: 10.1093/humrep/dev257. Epub 2015 Oct 13.

PMID:
26466909
14.

Assessment of ovarian reserve and fertility preservation strategies in children treated for cancer.

Guzy L, Demeestere I.

Minerva Ginecol. 2017 Feb;69(1):57-67. doi: 10.23736/S0026-4784.16.03992-7. Epub 2016 Oct 27. Review.

PMID:
27787477
15.

Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.

von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B.

Arch Gynecol Obstet. 2011 Aug;284(2):427-35. doi: 10.1007/s00404-011-1874-1. Epub 2011 Mar 24. Review.

16.

Fertility preservation options for female patients with malignancies.

Seli E, Tangir J.

Curr Opin Obstet Gynecol. 2005 Jun;17(3):299-308. Review.

PMID:
15870565
17.

Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.

Grynberg M, Poulain M, le Parco S, Sifer C, Fanchin R, Frydman N.

Hum Reprod. 2016 Mar;31(3):623-9. doi: 10.1093/humrep/dev325. Epub 2016 Jan 11.

PMID:
26759139
18.

Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.

Danis RB, Pereira N, Elias RT.

Curr Pharm Biotechnol. 2017 Nov 10;18(8):609-613. doi: 10.2174/1389201018666170808122531. Review.

PMID:
28786354
19.

Orthotopic autotransplantation of cryopreserved ovarian tissue to a woman cured of cancer - follicular growth, steroid production and oocyte retrieval.

Tryde Schmidt KL, Yding Andersen C, Starup J, Loft A, Byskov AG, Nyboe Andersen A.

Reprod Biomed Online. 2004 Apr;8(4):448-53.

PMID:
15149569
20.

Strategies to Maintain Fertility in Young Breast Cancer Patients.

Constance ES, Moravek MB, Jeruss JS.

Cancer Treat Res. 2018;173:1-13. doi: 10.1007/978-3-319-70197-4_1. Review.

PMID:
29349754

Supplemental Content

Support Center